These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical update: new drugs for HIV/AIDS. Gracia Jones S; Baggett TH Medsurg Nurs; 1999 Apr; 8(2):108-12. PubMed ID: 10410008 [TBL] [Abstract][Full Text] [Related]
7. Drugs for HIV infection. Med Lett Drugs Ther; 1997 Dec; 39(1015):111-6. PubMed ID: 9402928 [No Abstract] [Full Text] [Related]
8. New reverse transcriptase inhibitors. Crowe S Adv Exp Med Biol; 1999; 458():183-97. PubMed ID: 10549391 [No Abstract] [Full Text] [Related]
9. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV]. Bayonne Kombo ES; Gathse A Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355 [No Abstract] [Full Text] [Related]
10. [Nucleoside analogs inhibiting reverse transcriptase: use in adult patient with HIV infection]. Aguirrebengoa K; Mallolas J; Uriz J; Torres Tortosa M Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():3-9. PubMed ID: 9053024 [No Abstract] [Full Text] [Related]
11. What they say about: nucleoside drugs. Posit Aware; 2000; 11(1):37-43. PubMed ID: 11366349 [TBL] [Abstract][Full Text] [Related]
12. In vitro and ex vivo inhibition of human telomerase by anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs) but not by non-NRTIs. Hukezalie KR; Thumati NR; Côté HC; Wong JM PLoS One; 2012; 7(11):e47505. PubMed ID: 23166583 [TBL] [Abstract][Full Text] [Related]
13. [Protease inhibitor or non-nucleoside reverse transcriptase inhibitor. ACTG study 5202 in focus]. MMW Fortschr Med; 2010 Apr; 152(17):68-9. PubMed ID: 20509268 [No Abstract] [Full Text] [Related]
14. What they say about nucleoside drugs. Posit Aware; 1999; 10(1):28-34. PubMed ID: 11366520 [TBL] [Abstract][Full Text] [Related]
15. Drugs for HIV infection. Med Lett Drugs Ther; 2000 Jan; 42(1069):1-6. PubMed ID: 10683666 [No Abstract] [Full Text] [Related]
17. Long-term efficacy of a protease inhibitor-sparing, nucleoside reverse transcriptase inhibitor-limiting antiretroviral regimen with nevirapine, lamivudine, and reduced standard stavudine dosage. Shalit P; Farrell P; McClarty M HIV Clin Trials; 2004; 5(1):62-4. PubMed ID: 15002088 [No Abstract] [Full Text] [Related]
18. Stavudine plus a non-thymidine nucleoside reverse transcriptase inhibitor as a backbone for highly active antiretroviral therapy. Clumeck N Antivir Ther; 1998; 3 Suppl 4():39-43. PubMed ID: 10723508 [TBL] [Abstract][Full Text] [Related]
19. European Commission approves Atripla. AIDS Patient Care STDS; 2008 Jan; 22(1):87-8. PubMed ID: 18453042 [No Abstract] [Full Text] [Related]
20. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. Staszewski S; Morales-Ramirez J; Tashima KT; Rachlis A; Skiest D; Stanford J; Stryker R; Johnson P; Labriola DF; Farina D; Manion DJ; Ruiz NM N Engl J Med; 1999 Dec; 341(25):1865-73. PubMed ID: 10601505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]